Relapsing Multiple Sclerosis research hub
11 indexed studies · 4 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
An Adaptive Phase 2a/2b, Randomized, Double-Blind, Parallel-Group Study to Investigate the Safety and Efficacy of LY3541860 Compared to Placebo in Slowing the Occurrence of New T1 Gadolinium-Enhancing Lesions in Adult Participants with Relapsing Multiple Sclerosis
This study is looking into a new medicine, LY3541860, for people with relapsing multiple sclerosis (RMS). Researchers want to see if it can reduce the number of new spots on the brain (lesions) compared to a dummy treatment (placebo).
Italy · Lithuania · Germany - active not recruitingPHASE3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
This study looks at the long-term safety and effectiveness of a medicine called ofatumumab for people with relapsing MS. It also checks how well vaccines work in people taking this medicine, including those for flu, pneumonia, tetanus, and COVID-19.
United States · Argentina · Australia - active not recruitingPHASE3
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
This study is looking at a new medicine called fenebrutinib for people with a type of multiple sclerosis (MS) called relapsing MS. It compares fenebrutinib to an existing medicine, teriflunomide, to see if it works better and is safe.
United States · Austria · Brazil - active not recruitingPHASE3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)
This study is comparing a new medication called remibrutinib with an existing treatment, teriflunomide, for people with relapsing multiple sclerosis (RMS). It aims to see how well remibrutinib works and if it's safe to use in managing RMS symptoms.
United States · Argentina · Austria - active not recruitingPHASE3
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
This study looks at the everyday safety and how well a drug called tolebrutinib is tolerated over a long time. It's for adults with different types of multiple sclerosis (MS) who have already been in earlier tolebrutinib studies.
United States · Argentina · Australia - active not recruitingPHASE3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)
This study is looking at a new medicine called remibrutinib for people with relapsing multiple sclerosis (RMS). It compares remibrutinib to an existing medicine, teriflunomide, to see how well it works and if it's safe. It's a large study, involving about 800 people.
United States · Argentina · Brazil - recruitingPHASE3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
This study looks at a new medicine called remibrutinib for people with relapsing multiple sclerosis (RMS). It compares switching from their current medicine, ocrelizumab, to remibrutinib, versus staying on ocrelizumab, to see if it's safe and works well.
United States · Argentina · Australia - active not recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
This study is looking at a new medicine called fenebrutinib for people with relapsing multiple sclerosis (RMS). It wants to see if fenebrutinib is safe and works better than an existing medicine, teriflunomide, at slowing down the disease and reducing flare-ups.
United States · Argentina · China - recruiting
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
This study looks at different approved medicines for Relapsing Multiple Sclerosis (RMS) in Germany. It observes patients already starting these treatments to see how they work in real-world settings over several years.
Germany - active not recruitingPHASE2
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
The MoonStone study is looking at a new medicine called obexelimab for people with relapsing multiple sclerosis (MS). It aims to see if obexelimab can help and if it's safe. Participants will get either the new medicine or a dummy treatment, then everyone will get the new medicine.
United States · Austria · Belgium - recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
This study looks at the real experiences of people in the UK taking a new medicine called BRIUMVI® for a type of multiple sclerosis (MS) called relapsing MS. Researchers want to understand how well it works and if it’s safe in everyday life, not just in strict trial settings. It's an observational study, meaning participants take the medicine as prescribed by their doctor.
United States · Puerto Rico · United Kingdom